Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-(4'-nitrophenyl)-2-propen-1-ol, also known as p-nitrostyrene or 4-nitro-1-phenyl-2-propene-1-ol, is a chemical compound with the molecular formula C9H9NO3. It is a derivative of styrene, characterized by a phenyl ring with a nitro group and a hydroxyl group attached to a propene chain. 1-(4'-nitrophenyl)-2-propen-1-ol is recognized for its applications in various industries due to its unique chemical structure and properties.

123232-63-3

Post Buying Request

123232-63-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

123232-63-3 Usage

Uses

Used in Organic Synthesis:
1-(4'-nitrophenyl)-2-propen-1-ol is used as a starting material or intermediate for [application reason] in the field of organic synthesis. Its unique structure allows for further chemical reactions and modifications, making it a valuable component in creating more complex molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(4'-nitrophenyl)-2-propen-1-ol is used as a starting material or intermediate for [application reason] in drug development. Its properties make it a promising candidate for the creation of new medications and therapeutic compounds.
Used in Dye Production:
1-(4'-nitrophenyl)-2-propen-1-ol is used as a chemical intermediate for [application reason] in the production of dyes. Its chemical structure contributes to the color and stability of the dyes, making it an essential component in this application.
Used in Fragrance Industry:
Within the fragrance industry, 1-(4'-nitrophenyl)-2-propen-1-ol is used as a starting material or intermediate for [application reason] in the creation of various scent compounds. Its unique chemical properties allow for the development of distinct and complex fragrances.
Used in Fine Chemicals Production:
1-(4'-nitrophenyl)-2-propen-1-ol is also utilized as a starting material or intermediate for [application reason] in the production of fine chemicals. Its versatility in chemical reactions makes it a valuable asset in this field.
Safety Precautions:
It is crucial to handle 1-(4'-nitrophenyl)-2-propen-1-ol with care, as it is considered toxic and may cause skin and eye irritation upon contact. Proper safety measures, including the use of personal protective equipment (PPE) and adherence to safety protocols, should be taken to minimize the risk of exposure and potential health hazards.

Check Digit Verification of cas no

The CAS Registry Mumber 123232-63-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,3,2,3 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 123232-63:
(8*1)+(7*2)+(6*3)+(5*2)+(4*3)+(3*2)+(2*6)+(1*3)=83
83 % 10 = 3
So 123232-63-3 is a valid CAS Registry Number.

123232-63-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(4-nitrophenyl)prop-2-en-1-ol

1.2 Other means of identification

Product number -
Other names 1-Nppeo

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:123232-63-3 SDS

123232-63-3Relevant articles and documents

Enantioselective synthesis of 3-substituted 1,2-oxazinanes via organocatalytic intramolecular aza-Michael addition

Cheng, Shuanghua,Yu, Shouyun

, p. 8607 - 8610 (2014)

A highly enantioselective intramolecular 6-exo-trig aza-Michael addition was developed to afford chiral 3-substituted 1,2-oxazinanes in high yields (up to 99% yield) and good enantioselectivities (up to 98/2 er). These reactions were enabled by a quinine-derived primary-tertiary diamine as a catalyst and pentafluoropropionic acid (PFP) as a co-catalyst.

Study of Intermediates in Iridium-(Phosphoramidite,Olefin)-Catalyzed Enantioselective Allylic Substitution

R?ssler, Simon L.,Krautwald, Simon,Carreira, Erick M.

, p. 3603 - 3606 (2017)

Experimental mechanistic studies of iridium-catalyzed, enantioselective allylic substitution enabled by (phosphoramidite,olefin) ligands are reported. (η2-Allylic alcohol)iridium(I) and (η3-allyl)iridium(III) complexes were synthesiz

Sequential deoxyfluorination approach for the synthesis of protected α,β,γ-trifluoro-δ-amino acids

Cheerlavancha, Raju,Lawer, Aggie,Cagnes, Marina,Bhadbhade, Mohan,Hunter, Luke

, p. 5562 - 5565 (2013)

Backbone-homologated amino acids have been synthesized, containing three vicinal fluorine atoms placed stereospecifically along the carbon chain. Different trifluoro stereoisomers are found to have contrasting conformations, consistent with known stereoel

Synthesis of 2-(3-Arylallylidene)-3-oxindoles via Dirhodium(II)-Catalyzed Reaction of 3-Diazoindolin-2-imines with 1-Aryl-Substituted Allylic Alcohols and Computational Insights

Gao, Ke,Kou, Luyao,Fu, Rui,Bao, Xiaoguang

, p. 1292 - 1297 (2020)

A straightforward approach for the synthesis of 2-(3-arylallylidene)-3-oxindoles has been achieved by the dirhodium(II)-catalyzed reaction of 3-diazoindolin-2-imines with 1-aryl-substituted allylic alcohols. This protocol employs easily accessible feedsto

The Pharmacological Heterogeneity of Nepenthone Analogs in Conferring Highly Selective and Potent κ-Opioid Agonistic Activities

Li, Wei,Long, Jian-Dong,Qian, Yuan-Yuan,Long, Yu,Xu, Xue-Jun,Wang, Yu-Jun,Shen, Qing,Wang, Zuo-Neng,Yang, Xi-Cheng,Xiao, Li,Sun, Hong-Peng,Xu, Yu-Long,Chen, Yi-Yi,Xie, Qiong,Wang, Yong-Hui,Shao, Li-Ming,Liu, Jing-Gen,Qiu, Zhui-Bai,Fu, Wei

, p. 766 - 776 (2017)

To develop novel analgesics with no side effects or less side effects than traditional opioids is highly demanded to treat opioid receptor mediated pain and addiction issues. Recently, κ-opioid receptor (KOR) has been established as an attractive target,

Synthesis of C5-allylindoles through an iridium-catalyzed asymmetric allylic substitution/oxidation reaction sequence of N-alkyl indolines

Lu, Jiamin,Xu, Ruigang,Zeng, Haixia,Zhong, Guofu,Wang, Meifang,Ni, Zhigang,Zeng, Xiaofei

supporting information, p. 3426 - 3431 (2021/05/07)

Iridium/Br?nsted acid cooperative catalyzed asymmetric allylic substitution reactions at the C5 position of indolines have been reported for the first time. The highly efficient protocol allows rapid access to various C5-allylated products in good to high

Mild Darzens Annulations for the Assembly of Trifluoromethylthiolated (SCF3) Aziridine and Cyclopropane Structures

Delost, Michael D.,Njardarson, Jon T.

supporting information, p. 6121 - 6125 (2021/08/16)

We report mild new annulation approaches to trisubstituted trifluoromethylthiolated (SCF3) aziridines and cyclopropanes via Darzens inspired protocols. The products of these anionic annulations, rarely studied previously, possess attractive features rendering them valuable building blocks for synthesis platforms. In this study, trisubstituted acetophenone nucleophiles bearing SCF3 and bromine substituents in their α position were shown to undergo [2 + 1] annulations with vinyl ketones and tosyl-protected imines under mild reaction conditions.

Size-Exclusion Borane-Catalyzed Domino 1,3-Allylic/Reductive Ireland–Claisen Rearrangements: Impact of the Electronic and Structural Parameters on the 1,3-Allylic Shift Aptitude

Fegyverneki, Dániel,Kolozsvári, Natália,Molnár, Dániel,Egyed, Orsolya,Holczbauer, Tamás,Soós, Tibor

supporting information, p. 2179 - 2183 (2019/01/04)

The reductive Ireland–Claisen rearrangement through borane-mediated hydrosilylation is reported. The method employs a borane catalyst with a special structural design and affords access to synthetically relevant products with high diastereoselectivity. Depending on electronic and structural parameters, the reaction can be coupled with a 1,3-allylic shift, thus the valence isomer of the Ireland–Claisen product is formed.

Manganese-Catalyzed Ring-Opening Coupling Reactions of Cyclopropanols with Enones

Zhang, Yong-Hui,Zhang, Wen-Wei,Zhang, Ze-Yu,Zhao, Kai,Loh, Teck-Peng

supporting information, p. 5101 - 5105 (2019/07/03)

A manganese-catalyzed ring-opening coupling reaction of cyclopropanols with enones for the facile and efficient preparation of 1,6-diketones is described. A wide array of synthetically important 1,6-diketones bearing manifold functional groups are obtained with up to 93% yield. These reactions feature broad substrate scopes, environmentally benign conditions, inexpensive catalyst, and operational simplicity.

Structural Modification of Natural Product Ganomycin i Leading to Discovery of a α-Glucosidase and HMG-CoA Reductase Dual Inhibitor Improving Obesity and Metabolic Dysfunction in Vivo

Wang, Kai,Bao, Li,Zhou, Nan,Zhang, Jinjin,Liao, Mingfang,Zheng, Zhongyong,Wang, Yujing,Liu, Chang,Wang, Jun,Wang, Lifeng,Wang, Wenzhao,Liu, Shuangjiang,Liu, Hongwei

, p. 3609 - 3625 (2018/05/01)

It is a great challenge to develop drugs for treatment of metabolic syndrome. With ganomycin I as a leading compound, 14 meroterpene derivatives were synthesized and screened for their α-glucosidase and HMG-CoA reductase inhibitory activities. As a result, a α-glucosidase and HMG-CoA reductase dual inhibitor ((R,E)-5-(4-(tert-butyl)phenyl)-3-(4,8-dimethylnona-3,7-dien-1-yl)furan-2(5H)-one, 7d) with improved chemical stability and long-term safety was obtained. Compound 7d showed multiple and strong in vivo efficacies in reducing weight gain, lowering HbAlc level, and improving insulin resistance and lipid dysfunction in both ob/ob and diet-induced obesity (DIO) mice models. Compound 7d was also found to reduce hepatic steatosis in ob/ob model. 16S rRNA gene sequencing, SCFA, and intestinal mucosal barrier function analysis indicated that gut microbiota plays a central and causative role in mediating the multiple efficacies of 7d. Our results demonstrate that 7d is a promising drug candidate for metabolic syndrome.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 123232-63-3